Senti Biosciences Holdings (SNTI) Cash & Equivalents (2021 - 2026)
Senti Biosciences Holdings (SNTI) posted Cash & Equivalents of $6.5 million for Q2 2026, down 69.9% from $21.6 million a year earlier.
Powered by 
Analysis
Senti Biosciences Holdings (SNTI) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Senti Biosciences Holdings' Cash & Equivalents came in at $16.42 million, down 66.0% from FY2024.
- Annual Cash & Equivalents shows a four-year compound annual growth rate of -26.4% (FY2021 to FY2025).
- In prior years, Senti Biosciences Holdings' Cash & Equivalents was $48.3 million in FY2024 (+34.4%), $35.93 million in FY2023 (-37.7%), $57.62 million in FY2022 (+2.8%) and $56.03 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents in data going back to Q2 2021.
- On a year-over-year basis, Cash & Equivalents increased in four of the last seven quarters, with an average decline of 11.4%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2022, with growth of 68.6%; the weakest was Q2 2023, with a decline of 73.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Senti Biosciences Holdings | 9.97 Mn | 9.97 Mn | - | 6.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.50 Mn |
| Dec 31, 2025 | 16.42 Mn |
| Sep 30, 2025 | 12.24 Mn |
| Jun 30, 2025 | 21.60 Mn |
| Mar 31, 2025 | 33.80 Mn |
| Dec 31, 2024 | 48.30 Mn |
| Sep 30, 2024 | 10.50 Mn |
| Jun 30, 2024 | 15.90 Mn |
| Mar 31, 2024 | 23.72 Mn |
| Dec 31, 2023 | 35.93 Mn |
| Sep 30, 2023 | 39.43 Mn |
| Jun 30, 2023 | 36.75 Mn |
| Mar 31, 2023 | 31.60 Mn |
| Dec 31, 2022 | 57.62 Mn |
| Sep 30, 2022 | 114.94 Mn |
| Jun 30, 2022 | 139.80 Mn |
| Mar 31, 2022 | 38.14 Mn |
| Dec 31, 2021 | 56.03 Mn |
| Sep 30, 2021 | 73.69 Mn |
| Jun 30, 2021 | 82.94 Mn |
API Access
Senti Biosciences Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SNTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SNTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SNTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();